Bleakley Financial Group LLC Has $751,000 Position in Nutrien Ltd. (NYSE:NTR)

Bleakley Financial Group LLC raised its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,776 shares of the company’s stock after buying an additional 855 shares during the quarter. Bleakley Financial Group LLC’s holdings in Nutrien were worth $751,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. HHM Wealth Advisors LLC increased its stake in shares of Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after acquiring an additional 480 shares during the last quarter. Exchange Traded Concepts LLC increased its position in Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after purchasing an additional 416 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in Nutrien in the 4th quarter worth about $67,000. Larson Financial Group LLC raised its stake in shares of Nutrien by 1,370.6% during the 3rd quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock worth $77,000 after purchasing an additional 1,494 shares in the last quarter. Finally, Cromwell Holdings LLC lifted its holdings in shares of Nutrien by 113.4% during the 3rd quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock valued at $82,000 after buying an additional 900 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Down 0.4 %

NTR opened at $50.32 on Monday. The business has a 50 day moving average of $48.73 and a 200-day moving average of $48.10. The stock has a market capitalization of $24.71 billion, a price-to-earnings ratio of 33.77, a P/E/G ratio of 1.13 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 1-year low of $43.69 and a 1-year high of $60.87.

Analyst Upgrades and Downgrades

A number of research firms recently commented on NTR. Wells Fargo & Company increased their price objective on Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 28th. TD Securities dropped their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Raymond James raised shares of Nutrien from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. Finally, Oppenheimer initiated coverage on Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target for the company. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Nutrien has a consensus rating of “Moderate Buy” and an average price target of $58.94.

View Our Latest Stock Analysis on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.